U.S., June 2 -- ClinicalTrials.gov registry received information related to the study (NCT07618936) titled 'Programmed Cell Death Ligand 1 PET/CT in Various PD-L1-Related Disease Patients' on May 24.
Brief Summary: To evaluate the potential usefulness of 68Ga/18F-PD-L1 positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various PD-L1-related disease patients
Study Start Date: June 01
Study Type: OBSERVATIONAL
Condition:
PD-L1 Gene Mutation
PD-L1 Gene Amplification
PD-L1-related Disease
Positron Emission Tomography
Intervention:
DIAGNOSTIC_TEST: Single Group Assignment
Each subject receive a single intravenous injection of 68Ga/18F-DMP10 or other PDL1 tracers, and undergo P...